《2023年美国肝病学会实践指南: 慢加急性肝衰竭和肝硬化危重症患者管理》摘译
DOI: 10.12449/JCH240406
利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:熊号峰负责翻译;孙丽莹负责审校。
An excerpt of American Association for the Study of Liver Diseases practice guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis in 2023
-
摘要: 美国肝病学会专家小组于2023年11月9日在Hepatology发表了慢加急性肝衰竭(ACLF)和肝硬化危重症患者管理实践指南。该指南对ACLF的定义、预测模型、肝硬化合并ACLF和/或危重症患者脏器功能衰竭管理等进行了详细地阐述,本文对其要点进行摘译。Abstract: The expert panel of American Association for the Study of Liver Diseases published Practice guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis on November 9, 2023 in Hepatology. This practice guidance elaborates on the definition of acute-on-chronic liver failure, prediction models, and the management of liver cirrhosis comorbid with acute-on-chronic liver failure and organ failure in critically ill patients, and this article gives an excerpt of the key points in the practice guidance.
-
Key words:
- Acute-On-Chronic Liver Failure /
- Liver Cirrhosis /
- Therapeutics /
- United States
-
[1] KARVELLAS CJ, BAJAJ JS, KAMATH PS, et al. AASLD practice guidance on acute-on-chronic liver failure and the management of critically Ill patients with cirrhosis[J]. Hepatology, 2023. DOI: 10.1097/HEP.0000000000000671.[ Online ahead of print]
本文二维码
计量
- 文章访问数: 666
- HTML全文浏览量: 213
- PDF下载量: 205
- 被引次数: 0